News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,214 Results
Type
Article (71597)
Company Profile (439)
Press Release (664178)
Section
Business (199391)
Career Advice (3513)
Deals (36420)
Drug Delivery (110)
Drug Development (85903)
Employer Resources (179)
FDA (16750)
Job Trends (15593)
News (348383)
Policy (34279)
Tag
Academia (2964)
Alliances (50129)
Alzheimer's disease (1329)
Approvals (16659)
Artificial intelligence (153)
Bankruptcy (339)
Best Places to Work (12082)
Biotechnology (334)
Breast cancer (130)
Cancer (1172)
Cardiovascular disease (106)
Career advice (2978)
Cell therapy (270)
Clinical research (67811)
Collaboration (415)
Compensation (202)
COVID-19 (2747)
C-suite (106)
Data (1155)
Diabetes (166)
Diagnostics (6464)
Drug pricing (100)
Earnings (73101)
Employer resources (158)
Events (116556)
Executive appointments (325)
FDA (17315)
Funding (379)
Gene therapy (203)
GLP-1 (669)
Government (4886)
Healthcare (20197)
Infectious disease (2834)
Inflammatory bowel disease (121)
Interviews (676)
IPO (16845)
Job creations (3911)
Job search strategy (2456)
Layoffs (478)
Legal (7941)
Lung cancer (189)
Manufacturing (190)
Medical device (13831)
Medtech (13836)
Mergers & acquisitions (19677)
Metabolic disorders (457)
Neuroscience (1629)
NextGen Class of 2024 (7273)
Non-profit (4900)
Northern California (1497)
Obesity (261)
Opinion (243)
Patents (109)
People (60990)
Phase I (21095)
Phase II (29689)
Phase III (22193)
Pipeline (467)
Postmarket research (2940)
Preclinical (9329)
Radiopharmaceuticals (258)
Rare diseases (246)
Real estate (6431)
Regulatory (22865)
Research institute (2588)
Resumes & cover letters (551)
Southern California (1324)
Startups (3762)
United States (14078)
Vaccines (619)
Weight loss (208)
Date
Today (1)
Last 7 days (702)
Last 30 days (3599)
Last 365 days (37380)
2024 (34315)
2023 (41569)
2022 (52777)
2021 (57711)
2020 (56454)
2019 (50060)
2018 (37980)
2017 (35072)
2016 (35102)
2015 (40741)
2014 (34020)
2013 (30021)
2012 (31565)
2011 (31786)
2010 (30427)
Location
Africa (1044)
Arizona (176)
Asia (43254)
Australia (7714)
California (3414)
Canada (1293)
China (259)
Colorado (153)
Connecticut (163)
Europe (100283)
Florida (469)
Georgia (121)
Illinois (398)
Indiana (199)
Kansas (99)
Maryland (602)
Massachusetts (2763)
Michigan (170)
Minnesota (278)
New Jersey (982)
New York (983)
North Carolina (795)
Northern California (1497)
Ohio (146)
Pennsylvania (851)
South America (1400)
Southern California (1324)
Texas (480)
Washington State (382)
736,214 Results for "ben gurion university of the negev".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ben-Gurion University and Soroka Medical Center Announce Strategic Collaboration for Novel Technologies in the Field of Bio-Convergence
Ben-Gurion University of the Negev (BGU) and Soroka Medical Center announced a strategic collaboration for the development of novel technologies in the filed of Bio-Convergence (a field that combines biology with computational technologies and engineering).
May 4, 2022
·
7 min read
Press Releases
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
October 23, 2024
·
4 min read
Business
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that Ben Cravatt, Ph.D., has joined the company’s board of directors.
May 22, 2024
·
2 min read
Drug Development
Ben-Gurion University Researchers to Develop Novel Biological Treatment for Inflammatory Bowel Diseases
Researchers at Ben-Gurion University of the Negev are developing a novel therapeutic strategy for treating Inflammatory Bowel Diseases by sequestering inflammation-inducing molecules secreted by gut bacteria.
August 11, 2021
·
4 min read
Business
OncoHost Collaborates with BGN Technologies to Predict Cancer Patient Response to Anti-PD-1 Treatment with IcAR Biosensing Tech
OncoHost today announced that it has signed an option agreement with BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), to receive a license for a novel biosensing technology called IcAR (Immuno-checkpoint Artificial Reporter). IcAR was developed by a team of researchers from BGU.
May 4, 2023
·
4 min read
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.
October 8, 2024
·
5 min read
·
Ben Hargreaves
Ben-Gurion University Researchers Develop Machine Learning Platform to Streamline Clinical Trials
Researchers at Ben-Gurion University of the Negev (BGU) have developed a novel platform to streamline clinical trials, lower costs, and increase the efficiency and success rate of the drug or medical device development process.
October 21, 2020
·
3 min read
Researchers at Ben-Gurion University Introduce Platform for the Design of New Antibiotics
BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev, introduces a novel method developed by researchers at Ben-Gurion University for screening and detecting new antibiotics.
February 10, 2020
·
3 min read
Manufacturing
Novo-Catalent Deal Represents ‘Defining Moment’ for CDMO Sector
Novo Holdings’ acquisition of Catalent has ignited concerns from industry stakeholders, who fear that the consolidation could limit competition, but there is also the possibility that the deal could represent an opportunity for smaller-scale CDMOs to find new partners.
November 13, 2024
·
4 min read
·
Ben Hargreaves
Deals
Royalty Financing Serves as Lifeline for Some Biopharma Companies in Uncertain Market
As traditional fundraising methods falter for smaller firms, the rise of royalty deals is reshaping how companies access capital, offering an alternative that bypasses equity dilution and debt.
October 2, 2024
·
5 min read
·
Ben Hargreaves
1 of 73,622
Next
